![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 17308-17314, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, December 26, 2001
We have previously shown that intraarticular
treatment with a hyaluronan (HA) preparation (840 kDa), HA84,
up-regulates heat shock protein 72 (Hsp72) expression and suppresses
degeneration of synovial cells in an arthritis model. In that study,
the HA84 administered was degraded into HA oligosaccharides in the
synovial tissue, suggesting that HA84 or degradation products of HA may up-regulate Hsp72 expression. Thus, in the present study, we examined the effects of HA of various molecular sizes on Hsp72 expression and
cell death in stressed cells. Western blotting analysis showed that
treatment of K562 cells with HA tetrasaccharides up-regulated Hsp72
expression after exposure to hyperthermia. On the other hand, treatment
of the cells with HA of other sizes (di-, hexa-, deca-,
dodecasaccharides), HA84, or tetrasaccharides of keratan sulfate did
not elicit any change in expression of the Hsp72 protein. Treatment of
the cells with tetrasaccharides of HA up-regulated not only expression
of the Hsp72 protein but also Hsp72 mRNA expression and enhanced
activation of HSF1, a transcription factor controlling Hsp72
expression, after exposure to hyperthermia. Because the level of Hsp72
protein was not affected by tetrasaccharides of HA when the K562 cells
were kept at 37 °C without any stress, it is evident that
tetrasaccharides of HA did not act as a stress factor. In addition,
tetrasaccharides of HA suppressed cell death in the case of K562 cells
exposed to hyperthermia and of PC12 cells under serum deprivation.
These results suggest that a certain size of oligosaccharides,
i.e. the tetrasaccharides of HA, up-regulates Hsp72
expression by enhancing the activation of HSF1 under stress conditions
and suppresses cell death.
Heat shock proteins
(Hsps)1 are induced to
suppress cell damage when cells are exposed to environmental insult (1,
2). Hsp70 suppresses apoptosis by preventing processing of caspase 3 (3, 4). It is well known that brief ischemia induces tolerance to
subsequent ischemia in hippocampal neurons as a result of the induction
of Hsp70 expression (5). We have previously shown that intraarticular
treatment with hyaluronan (HA) preparation (840 kDa), HA84, suppresses
degeneration of synovial cells in a canine arthritis model and
up-regulates Hsp72 expression (6, 7). In that study, we also injected
fluorescent-labeled HA84 in synovial tissues and found that some
labeled HA particles could not be detected by means of an HA-binding
protein that binds specifically to HA molecules larger than
decasaccharides (7). These observations suggested that HA
oligosaccharides formed through degradation of HA84 in the tissue might
suppress cell damage by up-regulating Hsp72 expression. In the present
study, we prepared HA oligosaccharides of various molecular sizes and
treated cultured cells with them under stress conditions in an effort
to understand the appropriate size of HA oligosaccharides required to
up-regulate Hsp72 expression or to suppress cell death. Effects of HA
molecules on Hsp72 were investigated by examining both Hsp72 protein
levels and Hsp72 mRNA levels, and the activation of heat shock
factor 1 (HSF1), a transcription factor controlling Hsps expression, in
K562 cells exposed to the stress of hyperthermia. HSF1 is known to be
transferred to the nucleus from the cytoplasm, and it binds to a heat
shock element (HSE) in the DNA (8, 9). Moreover, HSF1 is
phosphorylated, and its molecular weight thereby increases when
activated soon after heat shock treatment (9). In addition to Hsp72
expression and HSF1 activation, the effects of HA molecules on cell
death were investigated using K562 cells exposed to hyperthermia and PC12 cells under conditions of serum deprivation in the present study.
It has been reported that low molecular weight fragments of HA induce
angiogenesis (10) and/or induce the expression of genes involved in the
inflammatory response, e.g. genes for chemokines and
cytokines (11). In addition to these activities, we show here a novel
activity of HA oligosaccharides, the acceleration of Hsp72 expression
through activation of HSF1 under stress conditions and its suppressive
effect on cell death.
Materials--
HA, chondroitin sulfate C type, keratan sulfate,
chondroitinase ACI, and chondroitinase ACII were obtained from
Seikagaku Corporation (Tokyo, Japan). Other reagents and chemicals were obtained from commercial sources.
Preparation of Oligosaccharides--
Glycosaminoglycan
oligosaccharides were prepared by the modified method of Inoue and
Nagasawa (12). Saturated HA tetra-(HA4), hexa-
(HA6), octa-(HA8), deca-(HA10), and
dodeca- (HA12) saccharides were prepared from the
degradation products generated by treatment of HA with testicular
hyaluronidase (Biozyme Laboratory, Gwent, UK) in 0.1 M
sodium phosphate buffer, pH 5.3, containing 150 mM NaCl at
37 °C. Saturated disaccharides of HA (HA2) were prepared from the degradation products generated by treatment of HA with dimethyl sulfoxide containing 10% of 0.1 M HCl for 16 h at 95 °C. Unsaturated HA di- (
All oligosaccharides were checked by Limulus amebocyte lysate assays
using Toxicolor LS Set (Seikagaku Corporation). HA4
contains 0.03 pg/mg endotoxins, and similar results were obtained in
other oligosaccharides.
Sizes and purity of HA oligosaccharides were determined by HPLC,
fluorophore-assisted carbohydrate electrophoresis, and mass spectrometry.2 Assignments of
1H and 13C NMR spectroscopy and of element
analysis were obtained for each HA oligosaccharide.2
Oligosaccharides of chondroitin, chondroitin sulfate C type, and
keratan sulfate were analyzed by HPLC and/or capillary electrophoresis (data not shown). In addition, keratan sulfate oligosaccharides have
been analyzed by mass spectrometry (13).
Culture of K562 Cells for Detection of Hsp72 and
HSF1--
Western blotting was done with K562 cells that were
incubated in the presence of 0, 1, 10, or 100 ng/ml HA2,
To detect Hsp72 mRNA expression by Northern blotting, K562 cells
were incubated in the presence or absence of 1 ng/ml
To analyze HSF1 retained in the nuclear fraction by flow cytometry and
to observe the results of immunostaining specific for HSF1 by confocal
laser scanning microscopy, K562 cells were incubated in the presence or
absence of 1 ng/ml Antibodies Used in Immunostaining for Hsp72 and HSF1--
For
the detection of Hsp72, monoclonal anti-Hsp72 antibody (Amersham
Biosciences) was used as the first antibody, and horseradish peroxidase- or FITC-conjugated goat anti-mouse IgG (Jackson Laboratory, West Grove, PA) was used as the second antibody. For the detection of
HSF1, rabbit anti-HSF1 polyclonal antibody (Stressgene, Victoria, British Columbia, Canada) was used as the first antibody, and horseradish peroxidase- or FITC-conjugated goat anti-rabbit IgG (Jackson Laboratory) was used as the second antibody.
Western Blotting Analysis of Hsp72 and HSF1--
K562 cells were
surveyed by antibodies against Hsp72 or HSF1 described above. After
electrophoresis, the proteins were electroblotted onto a nitrocellulose
membrane. To reduce nonspecific interactions, the membrane was blocked
by incubation with 0.3% skim milk in Tris-buffered saline (TBS) at
37 °C for 1 h. Following incubation with the first antibodies
at 4 °C overnight, the membrane was washed three times with 0.1%
Tween 20 in TBS and incubated with the secondary antibodies described
above at 37 °C for 1 h. Color development was performed with
0.05% diaminobenzidine solution in TBS containing 0.01%
H2O2.
Northern Blotting Analysis of Hsp72--
Total RNA was prepared
from control K562 cells and each culture of
Confocal Laser Scanning Microscopy--
K562 cells were fixed
with 4% paraformaldehyde for 15 min at 4 °C, washed with PBS, and
then permeabilized by incubation in 0.01% Tween 80 in PBS for 1 h
at 4 °C. The cells were incubated with 1% bovine serum albumin in
PBS and then with 1:200 diluted rabbit anti-HSF1 polyclonal antibody
(Stressgene) overnight at 4 °C followed by FITC-conjugated goat
anti-rabbit IgG (1:100, Jackson Laboratory) for 1 h at room
temperature. Then they were observed using a confocal laser scanning
microscope (Leica, Heidelberg, Germany).
Flow Cytometry--
For detection of intracellular Hsp72 in K562
cells, we used the monoclonal anti-Hsp72 antibody as described above
and FITC-conjugated goat anti-mouse IgG (Jackson Laboratory). The cells
were fixed with 4% paraformaldehyde for 15 min at 4 °C, washed with
PBS, and then permeabilized by incubation in a solution of 0.01% Tween 80 in PBS for 1 h at 4 °C. The cells were incubated with 1%
bovine serum albumin in PBS for 1 h at 4 °C and then with
anti-Hsp72 antibody (1:200) overnight at 4 °C followed by
FITC-conjugated goat anti-mouse IgG (1:100) for 1 h at room temperature.
To detect nuclear HSF1 in K562 cells, we used rabbit anti-HSF1
polyclonal antibody and FITC-conjugated goat anti-rabbit IgG (Jackson
Lab.). Before immunostaining, the nuclear fraction was obtained by
mincing the cells in a HEPES buffer (10 mM HEPES-KOH, 10 mM KCl, 0.1 mM EDTA) using a Dounce homogenizer
followed by centrifugation at 1300 rpm for 5 min. Because activated
HSF1 binds HSE in the nucleus of heat shocked cells, HSF1 is retained
in the nucleus even after fractionation (14). HSF1 retained in the
nuclear fraction was measured by FACScan (Becton Dickinson, Franklin
Lake, NJ) after immunostaining for HSF1. Before immunostaining, the
nuclear fraction was incubated in HEPES buffer for 30 min to remove any
HSF1 not bound to HSE. The nuclear fraction was fixed with 4%
paraformaldehyde for 15 min at 4 °C and washed with PBS, and then
the nuclei were permeabilized by incubation in a solution of 0.01%
Tween 80 in PBS for 1 h at 4 °C. The samples were incubated
with 1% bovine serum albumin in PBS for 1 h at 4 °C and then
with anti-HSF1 antibody (1:200) overnight at 4 °C followed by
FITC-conjugated goat anti-rabbit IgG (1:100) for 1 h at room temperature.
After immunostaining for Hsp72, HSF1, or Annexin V staining, the cells
were analyzed by flow cytometry (FACScan, Becton-Dickinson) using an
instrument equipped with a 15-mA ion laser and with filter settings for
FITC. Ten thousand cells from each sample were computed in list mode,
and data analysis was done with a commercial software program
(CELLQuest, Becton-Dickinson). Analysis gates were set on leukocyte,
according to forward and side scatter properties.
Detection of Cell Death--
To evaluate the effect of
It has been reported that serum deprivation induces apoptosis in PC12
cells (15). PC12 cells were cultured under conditions of serum
deprivation in the presence of HA oligosaccharides, HA84, L4, L4L4,
Ch04, and ChS4 at 100 ng/ml. The cell death
assay was done by the trypan blue exclusion method, 24 h after the
start of culture. The survival rate of cells cultured in the absence of
serum but in the presence of 100 ng/ml nerve growth factor was taken to
be 100%.
Digestion of HA4--
One mg of HA4 was
digested with 0.01 units of chondroitinase ACII in 0.1 M
sodium acetate buffer, pH 6.0, at 37 °C for 20 h. The reaction
was stopped by boiling 3 min. Boiled chondroitinase ACII was added to
HA4 as a negative control. These samples were ultrafiltrated with Centricon Plus-20 10K (Millipore Co., Bedford, MA)
to remove endotoxins and separated by anion exchange chromatography. The separated oligosaccharides were identified by HPLC. These products
of HA4 were applied in the cell death assay using PC12 cells described above.
HPLC Procedures--
Normal phase HPLC was performed using
YMC-pack NH2 (4.0 × 250 mm, YMC, Kyoto, Japan).
Oligosaccharides were eluted with a linear gradient of 2-100% 0.8 M NaH2PO4 at a flow rate of 1.0 ml/min at 40 °C. Absorbance was monitored at 210 nm.
Statistical Analysis--
Comparisons were analyzed by using the
unpaired Student's t test or Dunnet multiple comparison test.
Effects of HA Oligosaccharides on Hsp72 Expression--
Hsp72
protein expression was detected even in non-treated K562 cells not
exposed to hyperthermia (Fig. 1,
A and B). The results showed that treatment of
the K562 cells with Effects of HA Oligosaccharides on HSF1 Activation--
Western
blotting analysis showed that treatment of the K562 cells with
The treatment with
Immunodeposits of HSF1 were detected in Effects of Tetrasaccharides of HA on Cell Death--
Treatment
with Effects of Digestion Product of HA4 on Cell
Death--
To confirm the effect of HA4 on the cell death
of PC12 cells, chondroitinase ACII digestion of HA4 was
examined. HPLC analysis showed that HA4 was depolymerized
into disaccharides ( Our experiment show that a critical size of HA oligosaccharides,
i.e. tetrasaccharides of HA, is required to up-regulate
Hsp72 expression including HSF1 activation in K562 cells exposed to the
stress of hyperthermia and to suppress cell death in the case of PC12
cells under conditions of serum deprivation. High molecular weight HA,
HA84, and other kinds of GAG oligosaccharides, i.e. L4,
L4L4, Ch04, or ChS4, showed little effect on
Hsp72 expression and/or cell death. HA6 oligomers have been
used as a tool for probing the cell surface in a study of HA receptor
function (16) and was shown to be the minimum size required to
effectively compete with native HA in binding to chondrocytes via CD44
surface receptors (17). K562 cells were used as CD44-negative cell
lines (18, 19). We also confirmed that CD44 expression on the K562 cell surface is very weak by flow cytometry (data not shown). The treatment with HA4 as well as Sistonen et al. have shown that HSF1 is transferred from the
cytoplasm to the nucleus in K562 cells after exposure to hyperthermia as demonstrated by a biochemical method examining nuclear and cytoplasmic fractions (20). It has been reported that there is a
significant decrease in the level of HSF in the nuclear fraction prepared from unshocked cells, whereas nuclei from heat-shocked cells
retain a high level of HSF (14). Because activated HSF1 binds to HSE in
the nucleus of heat shocked cells, the activated HSF1 is retained in
the nucleus even after fractionation (14). Activation of HSF1, which is
reflected by nuclear HSF1 levels, was up-regulated immediately after
exposure to hyperthermia and down-regulated 2 h after exposure to
hyperthermia in the Activation of HSF1 involves the conversion of HSF1 from a
latent cytoplasmic monomer to a trimeric nuclear protein complex that
controls the transcription of heat shock genes (21, 22). Nuclear
localization and DNA binding, which occur as the first step in
activation of HSF1, are not sufficient for the full transcriptional competence of HSF1 (8, 9). Phosphorylation is required as the second
step in HSF1 activation to stimulate transcription (9). Localization
and retention of HSF1 in the nucleus, which means DNA binding of HSF1,
was found to be accelerated by the The treatment with Cell death was suppressed in the case of cells treated with
HA4 as determined both 2 and 4 h after exposure to
hyperthermia in the present study. The suppression of cell death
observed 4 h after exposure to hyperthermia may be due to the
prior up-regulation of Hsp72 expression in cells treated with
PC12 cells undergo apoptosis when cultured under conditions of serum
deprivation (15, 25). To confirm the effect of HA oligosaccharides on
cell death in a cell type except for K562 cells under stress conditions
other than hyperthermia, we treated PC12 cells with HA oligosaccharides
under conditions of serum deprivation in the present study. In this
experiment, tetrasaccharides of HA were found to be more effective in
suppressing cell death than the other HA oligosaccharides tested.
Further experiments are required to elucidate the relationship between
cell death and Hsp72 expression in PC12 cells under conditions of serum
deprivation. After digestion of HA4 by chondroitinase ACII,
the product did not suppress cell death of PC12 cells, confirming the
specificity of the suppressive effect of HA4 on the cell death.
Hyaluronidase activity is known to be elevated in tumors (26) and
inflammatory tissues (27) and to depolymerize HA. Free radicals also
depolymerize HA in inflammatory tissues (28). It has been reported that
hyaluronic acid with a molecular mass about 1.2 MDa inhibits the
advanced glycation endproducts-induced activation of the transcription
factor nuclear factor-
Effect of Hyaluronan Oligosaccharides on the Expression of Heat
Shock Protein 72*
§,
,
,
,
,
,
Seikagaku Corporation, Tateno 3-1253, Higashiyamato-shi, Tokyo 207-0021, Japan and the ¶ Department
of Cell Biology and Anatomy, Osaka University Medical School,
Suita-shi, Osaka 565-0871, Japan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
HA2),
tetra-(
HA4), and hexa-(
HA6) saccharides were generated by enzymatic digestion of HA with chondroitinase ACI in 0.1 M acetate buffer, pH 6.0, at 30 °C and
separated by the same chromatography method as mentioned above.
Chondroitin tetrasaccharides (Ch04) were generated by
treatment of chondroitin sulfate C type with the dimethyl sulfoxide
containing HCl. Chondroitin sulfate C type tetrasaccharides
(ChS4) were prepared by testicular hyaluronidase (Biozyme)
digestion of chondroitin sulfate C type. Keratan sulfate
oligosaccharides, Gal(SO3)-GlcNAc(SO3) [L4]
and Gal(SO3)-GlcNAc(SO3)-Gal(SO3)-GlcNAc(SO3)
[L4L4], were prepared from a keratanase II (Seikagaku Corporation)
digest of keratan sulfate (shark fin, Seikagaku Corporation) through
sequential steps of gel filtration and anion exchange adsorption column
chromatography. The degraded oligosaccharides were divided into
fractions of each size by sequential steps of anion exchange chromatography.
HA4, HA6, HA10, HA12, HA84, or L4L4 at 43 °C for 20 min followed by
further incubation at 37 °C for 2 h. K562 cells incubated at
37 °C for 2 h and 20 min without any treatment were used as the
"no heat shock" normal control. Moreover, K562 cells
incubated in the presence of
HA4 at 37 °C for 2 h and 20 min were examined by Western blotting to investigate whether
Hsp72 expression is induced by
HA4 under non-stress
conditions. For the detection of Hsp72 protein expression by flow
cytometry, K562 cells were incubated in the presence or absence of 1 ng/ml
HA4 at 43 °C for 20 min followed by further incubation at 37 °C for 2 or 4 h.
HA4 at 43 °C for 20 min with or without further incubation at 37 °C for 30 min, 1 h, or 2 h. To evaluate HSF1 activation by
Western blotting, K562 cells were incubated with 0, 1, 10, or 100 ng/ml
HA4, HA4, HA6, HA8,
or HA84. The K562 cells were stressed at 42 or 43 °C for 20 min.
K562 cells incubated at 37 °C for 20 min without any treatment were
used as the no heat shock normal control.
HA4 at 43 °C for 20 min with or
without further incubation at 37 °C for 2 h. Moreover, to
investigate the effect of
HA4 on activation of HSF1
under non-stress conditions, K562 cells were incubated in the presence or absence of 1 ng/ml
HA4 for 2 h and 20 min at
37 °C.
HA4-treated cells. Each sample was fractionated
by electrophoresis on a 1% agarose-formaldehyde gel and transferred to
a nylon membrane. For hybridization, the membrane was incubated
overnight at 42 °C in the presence of a denatured
32P-labeled human hsp72 oligonucleotide probe
(Oncogene Science, Inc., Cambridge, MA) added to the prehybridization
solution. A labeled cDNA probe specific for
glyceraldehyde-3-phosphate dehydrogenase was used as a hybridization
control. The membrane was washed at room temperature in saline/sodium
phosphate/EDTA and then subjected to autoradiography.
HA4 on cell death induced by hyperthermia, K562 cells
were incubated with 1 ng/ml
HA4 for 20 min at 43 °C
followed by incubation for 2 or 4 h at 37 °C. K562 cells incubated for 4 h at 37 °C without any treatment were used as a
no heat shock normal control. Then these cells were incubated with
Annexin V (Bender Medsystems, Vienna, Austria), which binds to
phosphatidylserine exposed on the outer surface of the cell membrane of
dead cells, just after cell culture as described above. Cell death was
analyzed by flow cytometry (FACScan, Becton-Dickinson).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
HA4 up-regulated Hsp72 expression
2 h after exposure to hyperthermia (Fig. 1A). The same
result was obtained in the case of HA4-treated cells (data
not shown). The Hsp72 protein level was not changed by treatment with
HA2, HA6, HA84, L4L4 (Fig. 1A),
HA12 (data not shown), or HA10 (data not shown)
in the case of K562 cells exposed to hyperthermia. Hsp72 expression was
not affected by
HA4 treatment in the case of cells not
exposed to hyperthermia (Fig. 1B). Flow cytometry showed
that treatment with 1 ng/ml
HA4 up-regulated and
down-regulated Hsp72 expression 2 and 4 h after exposure to
hyperthermia, respectively (Fig. 2).
Northern blotting analysis showed that Hsp72 mRNA expression in K562 cells was up-regulated 30 min and 1 h after exposure to hyperthermia as a result of treatment with
HA4 (Fig.
3).

View larger version (52K):
[in a new window]
Fig. 1.
Western blotting of Hsp72. Hsp72 was
detected even in K562 cells incubated at 37 °C (A,
B). Hyperthermia treatment up-regulated the Hsp72 expression
(A). Treatment with
HA4, but not with
HA2, HA6, HA84, or L4L4, up-regulated more of
the Hsp72 expression in the K562 cells exposed to hyperthermia
(A). Hsp72 expression was not changed by the treatment with
the
HA4 treatment in the K562 cells incubated at
37 °C (B). bH, bacterial Hsp72 used as a
control.

View larger version (32K):
[in a new window]
Fig. 2.
Flow cytometric analysis of Hsp72
expression. Treatment with 1 ng/ml
HA4 up-regulated
and down-regulated the Hsp72 expression in K562 cells 2 and 4 h
after the exposure to hyperthermia, respectively. **, p < 0.01; *, p < 0.05 (Student's t
test).

View larger version (46K):
[in a new window]
Fig. 3.
Northern blotting of Hsp72. K562 cells
were incubated in the presence (+) or absence (
) of 1 ng/ml
HA4 after exposure to hyperthermia. The treatment with
HA4 up-regulated the Hsp72 mRNA expression in K562
cells 30 min and 1 h after the exposure to hyperthermia.
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
HA4 up-regulated the level of phosphorylated HSF1 (~80
kDa), i.e. an activated form of HSF1, and diminished the level of non-phosphorylated HSF1 (~70 kDa) in cells exposed to hyperthermia at 42 °C (Fig.
4A). In addition,
HA4 or
HA4 increased the levels of both
phosphorylated and non-phosphorylated HSF1 when the cells were exposed
to hyperthermia at 43 °C (Fig. 4B). Activation of HSF1
was little influenced by HA84 (Fig. 4B) or HA6
(data not shown). Treatment with HA8 up-regulated the level of non-phosphorylated HSF1 but not of phosphorylated HSF1 (Fig. 4B).

View larger version (62K):
[in a new window]
Fig. 4.
Western blotting of HSF1. K562 cells
were treated with
HA4, HA4, HA8,
or HA84 immediately after exposure to hyperthermia at 42 °C
(A), or 43 °C (B) for 20 min. The treatment
with
HA4 or HA4 up-regulated the level of an
activated form of HSF1 (A, B). bHF,
bacterial HSF1 used as a control. 70 kDa, non-phosphorylated
HSF1. 80 kDa, phosphorylated (activated) HSF1.
HA4 did not alter the retention of
HSF1 in the nucleus of cells cultured at 37 °C (Fig.
5). The level of HSF1 retained in the
nucleus was found to be elevated immediately after and 2 h after
exposure to hyperthermia (Fig. 5). The level of HSF1 retained in the
nucleus was even more elevated in the presence of
HA4
immediately after exposure to hyperthermia (Fig. 5). However, in cells
treated with
HA4, the level of HSF1 retained in the
nucleus was slightly diminished 2 h after exposure to hyperthermia (Fig. 5).

View larger version (29K):
[in a new window]
Fig. 5.
Flow cytometric analysis of the levels of
HSF1 retained in the nucleus fraction of K562 cells. K562 cells
were incubated in the presence or absence of 1 ng/ml
HA4
incubated at 37 °C for 2 h and 20 min (left column),
at 43 °C for 20 min (center column), and at
43 °C for 20 min followed by incubation at 37 °C for 2 h
(right column). The treatment with
HA4
up-regulated and down-regulated the level of nuclear HSF1 in the K562
cells immediately and 2 h after the exposure to hyperthermia,
respectively. **, p < 0.01; *, p < 0.05 (Student's t test).
HA4-treated
(Fig. 6B) as well as
non-treated (Fig. 6A) K562 cells not exposed to hyperthermia. After exposure to hyperthermia, immunodeposits of HSF1
were detected as aggregated granular structures in the K562 cells
incubated in the absence of
HA4 (Fig. 6, C
and E). The HSF1-positive granules in the cells incubated at
37 °C for a further 2 h (Fig. 6E) were slightly
larger in size than those observed immediately after exposure to
hyperthermia (Fig. 6C). The immunodeposits of HSF1 in the
K562 cells incubated in the presence of
HA4 (Fig. 6,
D and F) were finer than those in the cells
incubated in the absence of
HA4 (Fig. 6, C
and E) after exposure to hyperthermia.

View larger version (106K):
[in a new window]
Fig. 6.
Immunostaining of HSF1 in K562 cells
incubated in the presence (
HA4
(+)) or absence (
HA4 (
)) of 1 ng/ml
HA4. K562 cells were
incubated at 37 °C for 2 h and 20 min (A,
B), at 43 °C for 20 min (C, D), or
at 43 °C for 20 min followed by incubation at 37 °C for 2 h
(E, F). The hyperthermia treatment induced the
formation of aggregated granules of HSF1 (C, E).
The treatment with
HA4 suppressed the formation of
aggregated granules of HSF1 (D, F).
Bar = 10 µm.
HA4 suppressed cell death in the case of K562 cells
as determined 2 and 4 h after exposure to hyperthermia (Fig.
7). Apoptosis of PC12 cells under
conditions of serum deprivation was prevented by treatment of the cells
with tetrasaccharides of HA (Fig. 8). On
the other hand, treatment with the other HA oligosaccharides, HA84, L4,
L4L4, Ch04, or ChS4 faintly suppressed the cell
death (Fig. 8).

View larger version (21K):
[in a new window]
Fig. 7.
Flow cytometric analysis of cell death in the
case of K562 cells. K562 cells were incubated in the presence or
absence of 1 ng/ml
HA4 for 2 and 4 h at 37 °C
after exposure to hyperthermia. The treatment with
HA4
suppressed the cell death of K562 cells induced by the hyperthermia
both 2 and 4 h after the exposure to hyperthermia. **,
p < 0.01; *, p < 0.05 (Student's
t test).

View larger version (42K):
[in a new window]
Fig. 8.
Survival rates of PC12 cells under conditions
of serum deprivation in the presence or absence (None)
of several kinds of saccharides (100 ng/ml). The survival rate of
PC12 cells treated with nerve growth factor (NGF) was taken
to be 100%. The treatment with
HA4 or HA4
suppressed the cell death of PC12 cells. **, p < 0.01 (Dunnet multiple comparison test).
HA2 plus HA2) by the
treatment with chondroitinase ACII (Fig.
9). HA4 was not depolymerized
by the treatment with boiled chondroitinase ACII (Fig. 9). Apoptosis of
PC12 cells under conditions of serum deprivation was not prevented by
treatment of the cells with the digestion products of HA4,
i.e.
HA2 plus HA2 (Fig.
10), whereas apoptosis of PC12 cells
was suppressed by HA4 treated with boiled chondroitinase
ACII (Fig. 10).

View larger version (21K):
[in a new window]
Fig. 9.
HPLC analyses of the digestion product of
HA4. A, intact HA4. B,
HA4 treated with boiled chondroitinase ACII. C,
HA4 treated with chondroitinase ACII. HA4 was
degraded into HA2 plus
HA2. D,
mixture of HA oligosaccharides before isolating into each size of HA
oligosaccharides.

View larger version (17K):
[in a new window]
Fig. 10.
Effects of digestion product of
HA4 on cell death on the survival rates of PC12 cells under
conditions of serum deprivation. The apoptosis of PC12 cells was
not prevented by the treatment with HA4 digestion, that is
HA4 treated with chondroitinase ACII, i.e.
HA2 plus
HA2. HA4+
boil, HA4 treated with boiled chondroitinase ACII.
NGF, nerve growth factor.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
HA4 up-regulated the
Hsp72 expression in the present study, suggesting the possibility that
there may be as yet unidentified receptors for HA tetrasaccharides in
the cells that induce the signal transduction to up-regulate the Hsp72
expression. As shown by Western blotting, the treatment with
HA4 as well as HA4 activated HSF1,
indicating that the carboxyl group of the non-reducing end of HA
tetrasaccharides is not essential to up-regulate the activation of
HSF1. Hsp72 expression was not affected by
HA4 treatment
in the case of cells not exposed to hyperthermia, suggesting that
HA4 treatment does not induce Hsp72 expression under
non-stress conditions but up-regulates it under stress conditions.
HA4-treated cells as compared with
non-treated cells. In the
HA4-treated cells, Hsp72
expression was up- and down-regulated 2 and 4 h after exposure to
hyperthermia, respectively. Moreover, Hsp72 mRNA expression was
up-regulated 30 min and 1 h but not 2 h after exposure to hyperthermia in the
HA4-treated cells. These results
suggest that the treatment with
HA4 accelerates not only
HSF1 activation followed by the acceleration of Hsp72 expression but
also the feedback regulation that controls the disappearance of Hsp72
(Fig. 11).

View larger version (28K):
[in a new window]
Fig. 11.
Proposed mechanism of the effect of
HA4 on Hsp72 expression and cell death. The difference
in thickness of arrows between A and B
indicates intensities of activation of HSF1, transcription and
translation of Hsp72, and suppression of cell death. The treatment with
tetrasaccharides of HA up-regulates the activation of HSF1 to enhance
the level of Hsp72 expression and suppression of cell death.
HA4 treatment in the
present study. In addition, we showed that phosphorylation of HSF1 were
accelerated by the treatment with
HA4. Non-steroidal
anti-inflammatory drugs such as salicylate are known to enhance
thermotolerance in K562 cells by prolonging Hsp70 expression (23). Such
drugs induce HSF binding to HSE even under non-stress conditions, but
they are unable to induce Hsp70 transcription (24). In the present
study, retention of HSF1 in the nucleus was not changed by
HA4 treatment under non-stress conditions. This suggests
that the mechanism of the effect of non-steroidal anti-inflammatory
drugs on Hsp70 expression differs from that of
HA4. When
cells were exposed to severe hyperthermia (43 °C), treatment of
HA4 or HA4 up-regulated both non-activated (non-phosphorylated) and activated (phosphorylated) HSF1 levels. These
results indicate that the treatment of
HA4 or
HA4 induces not only the activation but also the synthesis
of HSF1.
HA4 suppressed the formation of
aggregated granules of HSF1 in cells exposed to hyperthermia. Sarge
et al. have shown that the kinetics of appearance of HSF1
granules in the nuclei of HeLa cells during heat shock is very well
correlated with the kinetics of HSF DNA binding and heat shock gene
transcription (20). Alternatively, they noted the possibility that the
granules observed may represent large aggregated particles of inactive HSF1. This coincides well with our present findings that the
HA4 treatment suppresses HSF1 formation of aggregated
granules of HSF1 and up-regulates the HSF1 activation as well as Hsp72
expression after exposure to hyperthermia. It seems likely that the
finer the HSF1 particles, the sooner the HSF1 can move between nucleus and cytoplasm. This coincides well with the result that disappearance as well as expression of Hsp72 protein were also accelerated by the
treatment with
HA4 (Fig. 11). Further studies, however,
are required to elucidate the precise mechanism involved in the
activation of HSF1 by
HA4.
HA4 because the Hsp72 level was lower in the
HA4-treated cells than non-treated cells 4 h after
exposure to hyperthermia (Fig. 11).
B (NF-
B) and the NF-
B-regulated
cytokines interleukin-1
, interleukin-6, and tumor necrosis
factor-
(29). In addition to it, expression of interleukin-1
mRNA in synovium has been suppressed in the mild grades of
osteoarthritis by the intraarticular treatment with high molecular mass
HA (about 1.0 MDa) (30). Moreover, high molecular mass HA is known to
suppress the proliferation of endothelial cells (31). On the contrary,
it is well known that low molecular weight HA induces angiogenesis (10)
and inflammation (11). When HA is natively depolymerized by
hyaluronidases or radicals in vivo, HA may acquire novel
functions. One of them is the up-regulation of Hsp72 expression (Fig.
12).

View larger version (28K):
[in a new window]
Fig. 12.
Cell biological activities of hyaluronan
depending on its molecular sizes. See "Discussion" for
details.
In conclusion, our results show that tetrasaccharides of HA up-regulate
Hsp72 expression by enhancing the activation of HSF1 under stress
conditions and suppress cell death (Fig. 12).
| |
ACKNOWLEDGEMENT |
|---|
We thank Dr. Hascall at the Cleveland Clinic Foundation for review of this manuscript.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Present address: Dept. of Ophthalmology, University of Aberdeen Medical School, Foresterhill, Aberdeen AB25 2ZD, United Kingdom.
To whom correspondence should be addressed. Tel.:
81-42-563-5830; Fax: 81-42-563-5847; E-mail:
asari@seikagaku.co.jp.
Published, JBC Papers in Press, February 25, 2002, DOI 10.1074/jbc.M112371200
2 A. Tawada, T. Masa, Y. Oonuki, A. Watanabe, Y. Matsuzaki, and A. Asari, submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
Hsp(s), heat shock
proteins;
HA, hyaluronan;
HSF, heat shock factor;
HSE, heat shock
element;
HA4, HA tetrasaccharides;
HA6, HA
hexasaccharides;
HA8, HA octaasaccharides;
HA10, HA decaasaccharides;
HA12, HA
dodecaaccharides;
HA2, HA disaccharides;
HA2, unsaturated HA diasaccharides;
HA4, unsaturated HA tetrasaccharides;
HA6, unsaturated HA
hexasaccharides;
Ch04, chondroitin tetrasaccharides;
ChS4, chondroitin sulfate C type tetrasaccharides;
HPLC, high pressure liquid chromatography;
FITC, fluorescein isothiocyanate;
TBS, Tris-buffered saline;
PBS, phosphate-buffered saline.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ashburner, M.,
and Bonner, J. J.
(1979)
Cell
17,
241-254[CrossRef][Medline]
[Order article via Infotrieve] |
| 2. |
Lindquist, S.
(1986)
Annu. Rev. Biochem.
55,
1151-1191[CrossRef][Medline]
[Order article via Infotrieve] |
| 3. |
Mosser, D. D.,
Caron, A. W.,
Bourget, L.,
Denis-Larose, C.,
and Massie, B.
(1997)
Mol. Cell. Biol.
17,
5317-5327[Abstract] |
| 4. |
Buzzard, K. A.,
Giaccia, A. J.,
Killender, M.,
and Anderson, R. L.
(1998)
J. Biol. Chem.
273,
17147-17153 |
| 5. |
Kirino, T.,
Tsujita, Y.,
and Tamura, A.
(1991)
J. Cereb. Blood Flow Metab.
11,
299-307[Medline]
[Order article via Infotrieve] |
| 6. |
Asari, A.,
Miyauchi, S.,
Matsuzaka, S.,
Itoh, T.,
and Uchiyama, Y.
(1996)
Osteoarthritis Cartilage
4,
213-215[CrossRef][Medline]
[Order article via Infotrieve] |
| 7. |
Asari, A.,
Miyauchi, S.,
Matsuzaka, S.,
Itoh, T.,
Kominami, E.,
and Uchiyama, Y.
(1998)
Arch. Histol. Cytol.
61,
125-135[Medline]
[Order article via Infotrieve] |
| 8. |
Cotto, J. J.,
Kline, M.,
and Morimoto, R. I.
(1996)
J. Biol. Chem.
271,
3355-3358 |
| 9. |
Xia, W.,
and Voellmy, R.
(1997)
J. Biol. Chem.
272,
4094-4102 |
| 10. | West, D. C., and Shaw, D. M. (1998) in The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives (Laurent, T. C., ed) , pp. 227-233, Portland Press Ltd., London |
| 11. | Noble, P. W., McKee, C. M., and Horton, M. R. (1998) in The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives (Laurent, T. C., ed) , pp. 219-225, Portland Press Ltd., London |
| 12. |
Inoue, Y.,
and Nagasawa, K.
(1985)
Carbohydr. Res.
141,
99-110[CrossRef] |
| 13. | Kubota, M., Yoshida, K., Tawada, A., and Ohashi, M. (2000) Eur. J. Mass. Spectrom. 6, 193-203 |
| 14. |
Westwood, J. T.,
Clos, J.,
and Wu, C.
(1991)
Nature
353,
822-827[CrossRef][Medline]
[Order article via Infotrieve] |
| 15. |
Ohsawa, Y.,
Isahara, K.,
Kanamori, S.,
Shibata, M.,
Kametaka, S.,
Gotow, T.,
Watanabe, T.,
Kominami, E.,
and Uchiyama, Y.
(1998)
Arch. Histol. Cytol.
61,
395-403[Medline]
[Order article via Infotrieve] |
| 16. |
Knudson, C. B.
(1993)
J. Cell Biol.
120,
825-834 |
| 17. |
Knudson, C. B.,
and Kundson, W.
(1993)
FASEB J.
7,
1233-1241[Abstract] |
| 18. |
Dougherty, G. J.,
Landorp, P. M.,
Cooper, D. L.,
and Humphries, R. K.
(1991)
J. Exp. Med.
174,
1-5 |
| 19. |
Schrager, H. M.,
Alberti, S.,
Cywes, C.,
Dougherty, G. J.,
and Wessels, M. R.
(1998)
J. Clin. Invest.
101,
1708-1716[Medline]
[Order article via Infotrieve] |
| 20. |
Sistonen, L.,
Sarge, K. D.,
and Morimoto, R. I.
(1994)
Mol. Cell. Biol.
14,
2087-2099 |
| 21. |
Sarge, K. D.,
Murphy, S. P.,
and Morimoto, R. I.
(1993)
Mol. Cell. Biol.
13,
1392-1407 |
| 22. |
Wu, C.
(1995)
Annu. Rev. Cell Dev. Biol.
11,
441-469[CrossRef][Medline]
[Order article via Infotrieve] |
| 23. |
Amici, C.,
Rossi, A.,
and Santoro, M. G.
(1995)
Cancer Res.
55,
4452-4457 |
| 24. |
Jurivich, D. A.,
Sistonen, L.,
Kroes, R. A.,
and Morimoto, R. I.
(1992)
Science
255,
1243-1245 |
| 25. |
Isahara, K.,
Ohsawa, Y.,
Kanamori, S.,
Shibata, M.,
Waguri, S.,
Sato, N.,
Gotow, T.,
Watanabe, T.,
Momoi, T.,
Urase, K.,
Kominami, E.,
and Uchiyama, Y.
(1999)
Neuroscience
91,
233-249[CrossRef][Medline]
[Order article via Infotrieve] |
| 26. |
Lokeshwar, V. B.,
Rubinowicz, D.,
Schroeder, G. L.,
Forgacs, E.,
Minna, J. D.,
Block, N. L.,
Nadji, M.,
and Lokeshwar, B. L.
(2001)
J. Biol. Chem.
276,
11922-11932 |
| 27. |
Nagaya, H.,
Ymagata, T.,
Ymagata, S.,
Iyoda, K.,
Ito, H.,
Hasegawa, Y.,
and Iwata, H.
(1999)
Ann. Rheum. Dis.
58,
186-188 |
| 28. |
Deguine, V.,
Menasche, M.,
Ferrari, P.,
Fraisse, L.,
Pouliquen, Y.,
and Robert, L.
(1998)
Int. J. Biol. Macromol.
22,
17-22[CrossRef][Medline]
[Order article via Infotrieve] |
| 29. |
Neumann, A.,
Schinzel, R.,
Palm, D.,
Riederer, P.,
and Munch, G.
(1999)
FEBS Lett.
453,
283-287[CrossRef][Medline]
[Order article via Infotrieve] |
| 30. |
Takahashi, K.,
Goomer, R. S.,
Harwood, F.,
Kubo, T.,
Hirasawa, Y.,
and Amiel, D.
(1999)
Osteoarthritis Cartilage
7,
182-190[CrossRef][Medline]
[Order article via Infotrieve] |
| 31. |
West, D. C.,
and Kumar, S.
(1989)
CIBA Found. Symp.
143,
187-207[Medline]
[Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
H. Xu, H. Kurihara, T. Ito, H. Kikuchi, K. Yoshida, H. Yamanokuchi, and A. Asari The Keratan Sulfate Disaccharide Gal(6S03) {beta}1,4-GlcNAc(6S03) Modulates Interleukin 12 Production by Macrophages in Murine Thy-1 Type Autoimmune Disease J. Biol. Chem., May 27, 2005; 280(21): 20879 - 20886. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stern Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology, December 1, 2003; 13(12): 105R - 115R. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Sugahara, T. Murai, H. Nishinakamura, H. Kawashima, H. Saya, and M. Miyasaka Hyaluronan Oligosaccharides Induce CD44 Cleavage and Promote Cell Migration in CD44-expressing Tumor Cells J. Biol. Chem., August 22, 2003; 278(34): 32259 - 32265. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||